Skip to main content
Top
Gepubliceerd in: Quality of Life Research 10/2014

01-12-2014

Longitudinal quality of life data: a comparison of continuous and ordinal approaches

Auteurs: A. F. Donneau, M. Mauer, C. Coens, A. Bottomley, A. Albert

Gepubliceerd in: Quality of Life Research | Uitgave 10/2014

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Purpose

In cancer clinical trials, health-related quality of life (HRQoL) is a major outcome measure. It is generally assessed at specified time intervals by filling out a questionnaire with ordered response categories. Despite recent advances in the statistical methodology for handling ordinal longitudinal outcome data, most users keep treating HRQoL scales as continuous rather than ordinal variables regardless of the number of categories. The purpose of this study was to compare the results of analyzing HRQoL longitudinal data under both approaches, continuous and ordinal.

Methods

The EORTC QLQ-C30 scores of two EORTC randomized brain cancer clinical trials (26951 and 26981) were analyzed using the two approaches. In the 26951 trial, a total of 368 patients were randomly assigned to receive either radiotherapy (RT) or the same RT plus procarbazine, CCNU, and vincristine. In the 26981 trial, 573 patients were randomly allocated to RT or RT plus temozolomide. Comparison of the two treatment arms was done using methods for longitudinal quantitative and longitudinal ordinal data. Both statistical methods were adapted to account for missing data and compared in terms of statistical significance of the results (p values) but also with respect to data interpretation.

Results

Three scales, i.e., appetite loss, insomnia, and drowsiness, presenting four response categories ("Not at all", "A little", "Quite a bite", and "Very much") were analyzed in each trial. Both statistical methods (continuous and ordinal) showed statistically significant differences between the two treatments, not only globally but also at the same assessment time points. The magnitude of the p values, however, varied at some time points and was less pronounced in the ordinal approach.

Conclusions

The analysis of the two clinical trials showed that treating the HRQoL scales by a quantitative or an ordinal method did not make much difference as far as statistical significance was concerned. The interpretation of results, however, was easier under the ordinal approach. Treatment effects may be more meaningful when expressed in terms of odds ratios than as mean values, particularly when the number categories is small.
Literatuur
1.
go back to reference Olschewski, M., Schulgen, G., Schumacher, M., & Altman, D. G. (1994). Quality of life assessment in clinical cancer research. British Journal of Cancer, 70(1), 1–5.PubMedCentralPubMedCrossRef Olschewski, M., Schulgen, G., Schumacher, M., & Altman, D. G. (1994). Quality of life assessment in clinical cancer research. British Journal of Cancer, 70(1), 1–5.PubMedCentralPubMedCrossRef
2.
go back to reference Cox, D. R., & Snell, E. J. (1989). The Analysis of Binary Data (2nd ed.). London: Chapman & Hall. Cox, D. R., & Snell, E. J. (1989). The Analysis of Binary Data (2nd ed.). London: Chapman & Hall.
3.
go back to reference Agresti, A. (2013). Categorical data analysis (3rd ed.). New York: Wiley. Agresti, A. (2013). Categorical data analysis (3rd ed.). New York: Wiley.
4.
go back to reference Agresti, A. (2010). Analysis of ordinal categorical data (2nd ed.). New York: Wiley.CrossRef Agresti, A. (2010). Analysis of ordinal categorical data (2nd ed.). New York: Wiley.CrossRef
5.
go back to reference Lall, R., Campbell, M. J., Walters, S. J., Morgan, K., & MRC CFAS Co-operative. (2002). A review of ordinal regression models applied on health-related quality of life assessments. Statistical Methods in Medical Research, 11, 49–67.PubMedCrossRef Lall, R., Campbell, M. J., Walters, S. J., Morgan, K., & MRC CFAS Co-operative. (2002). A review of ordinal regression models applied on health-related quality of life assessments. Statistical Methods in Medical Research, 11, 49–67.PubMedCrossRef
6.
go back to reference Taphoorn, M. J., Stupp, R., Coens, C., Osoba, D., Kortmann, R., van den Bent, M. J., et al. (2005). Health-related quality of life in patients with glioblastoma: A randomized controlled trial. Lancet Oncology, 6(12), 937–944.CrossRef Taphoorn, M. J., Stupp, R., Coens, C., Osoba, D., Kortmann, R., van den Bent, M. J., et al. (2005). Health-related quality of life in patients with glioblastoma: A randomized controlled trial. Lancet Oncology, 6(12), 937–944.CrossRef
7.
go back to reference Taphoorn, M. J., van den Bent, M. J., Mauer, M., Coens, C., Delattre, J. Y., Brandes, A., et al. (2007). Health-related quality of life in patients treated for anaplastic oligodendroglioma with adjuvant chemotherapy: Results of a European Organisation for Research and Treatment of Cancer Randomized Clinical Trial. Journal of Clinical Oncology, 25(38), 5723–5730.PubMedCrossRef Taphoorn, M. J., van den Bent, M. J., Mauer, M., Coens, C., Delattre, J. Y., Brandes, A., et al. (2007). Health-related quality of life in patients treated for anaplastic oligodendroglioma with adjuvant chemotherapy: Results of a European Organisation for Research and Treatment of Cancer Randomized Clinical Trial. Journal of Clinical Oncology, 25(38), 5723–5730.PubMedCrossRef
8.
go back to reference Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., et al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85, 365–376.PubMedCrossRef Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., et al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85, 365–376.PubMedCrossRef
9.
go back to reference Taphoorn, M. J., Claassens, L., Aaronson, N. K., Coens, C., Mauer, M., Osoba, D., et al. (2010). An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients. European Journal of Cancer, 46, 1033–1040.PubMedCrossRef Taphoorn, M. J., Claassens, L., Aaronson, N. K., Coens, C., Mauer, M., Osoba, D., et al. (2010). An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients. European Journal of Cancer, 46, 1033–1040.PubMedCrossRef
10.
go back to reference Osoba, D., Aaronson, N. K., Muller, M., Sneeuw, K., Hsu, M. A., Yung, W., et al. (1996). The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires. Quality of Life Research, 5(1), 139–150.PubMedCrossRef Osoba, D., Aaronson, N. K., Muller, M., Sneeuw, K., Hsu, M. A., Yung, W., et al. (1996). The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires. Quality of Life Research, 5(1), 139–150.PubMedCrossRef
11.
go back to reference Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J., et al. (2005). Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. New England Journal of Medicine, 352(10), 987–996.PubMedCrossRef Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J., et al. (2005). Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. New England Journal of Medicine, 352(10), 987–996.PubMedCrossRef
12.
go back to reference Van den Bent, M. J., Carpentier, A. F., Brandes, A., Sanson, M., Taphoorn, M. J. B., Bernsen, H., et al. (2006). Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: A randomized european organisation for research and treatment of cancer phase III trial. Journal of Clinical Oncology, 24, 2715–2722.PubMedCrossRef Van den Bent, M. J., Carpentier, A. F., Brandes, A., Sanson, M., Taphoorn, M. J. B., Bernsen, H., et al. (2006). Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: A randomized european organisation for research and treatment of cancer phase III trial. Journal of Clinical Oncology, 24, 2715–2722.PubMedCrossRef
13.
go back to reference Verbeke, G., & Molenberghs, G. (2000). Linear mixed models for longitudinal data. New York: Springer. Verbeke, G., & Molenberghs, G. (2000). Linear mixed models for longitudinal data. New York: Springer.
14.
go back to reference McCullagh, P. (1980). Regression models for ordinal data (with discussion). Journal of the Royal Statistical Society, Series B, 42, 109–142. McCullagh, P. (1980). Regression models for ordinal data (with discussion). Journal of the Royal Statistical Society, Series B, 42, 109–142.
15.
go back to reference Rubin, D. B. (1976). Inference and missing data. Biometrika, 63, 581–592.CrossRef Rubin, D. B. (1976). Inference and missing data. Biometrika, 63, 581–592.CrossRef
16.
go back to reference Little, R. J. A., & Rubin, D. B. (1987). Statistical analysis with missing data. New-York: Wiley. Little, R. J. A., & Rubin, D. B. (1987). Statistical analysis with missing data. New-York: Wiley.
17.
go back to reference Donneau, A. F. (2013). Contribution to the statistical analysis of incomplete longitudinal ordinal data. PhD thesis, University of Liège, Belgium. Donneau, A. F. (2013). Contribution to the statistical analysis of incomplete longitudinal ordinal data. PhD thesis, University of Liège, Belgium.
18.
go back to reference Rubin, D. B. (1978). Multiple imputation in sample surveys—A phenomenological Bayesian approach to nonresponse. Imputation and Editing of Faulty or Missing Survey Data, Washington, DC: US Department of Commerce, pp. 1–32. Rubin, D. B. (1978). Multiple imputation in sample surveys—A phenomenological Bayesian approach to nonresponse. Imputation and Editing of Faulty or Missing Survey Data, Washington, DC: US Department of Commerce, pp. 1–32.
19.
go back to reference Carpenter, J. R., & Kenward, M. G. (2013). Multiple imputation and its application. New York: Wiley.CrossRef Carpenter, J. R., & Kenward, M. G. (2013). Multiple imputation and its application. New York: Wiley.CrossRef
20.
go back to reference Donneau, A. F., Mauer, M., Molenberghs, G., & Albert, A. (2013). A simulation study comparing multiple imputation methods for incomplete longitudinal ordinal data. Communications in Statistics—Simulation and Computation (in press). Donneau, A. F., Mauer, M., Molenberghs, G., & Albert, A. (2013). A simulation study comparing multiple imputation methods for incomplete longitudinal ordinal data. Communications in Statistics—Simulation and Computation (in press).
21.
go back to reference Donneau, A. F., Mauer, M., Lambert P., Molenberghs, G., & Albert, A. (2013). Simulation-based study comparing multiple imputation methods for non-monotone missing ordinal data in longitudinal settings Journal of Biopharmaceutical Statistics (in press). Donneau, A. F., Mauer, M., Lambert P., Molenberghs, G., & Albert, A. (2013). Simulation-based study comparing multiple imputation methods for non-monotone missing ordinal data in longitudinal settings Journal of Biopharmaceutical Statistics (in press).
22.
go back to reference Gorlia, T., van den Bent, M. J., Hegi, M. E., Mirimanoff, R. O., Weller, M., Cairncross, J. G., et al. (2008). Nomograms for predicting survival of patients with newly diagnosed glioblastoma multiforme: A prognostic factor analysis of EORTC/NCIC trial 26981–22981/CE. The Lancet Oncology, 9, 29–38.PubMedCrossRef Gorlia, T., van den Bent, M. J., Hegi, M. E., Mirimanoff, R. O., Weller, M., Cairncross, J. G., et al. (2008). Nomograms for predicting survival of patients with newly diagnosed glioblastoma multiforme: A prognostic factor analysis of EORTC/NCIC trial 26981–22981/CE. The Lancet Oncology, 9, 29–38.PubMedCrossRef
23.
go back to reference Rubin, D. B. (1987). Multiple imputations for nonresponse in survey. New York: Wiley.CrossRef Rubin, D. B. (1987). Multiple imputations for nonresponse in survey. New York: Wiley.CrossRef
24.
go back to reference Scott, N. W., Fayers, P. M., Aaronson, N. K., Bottomley, A., de Graeff, A., Groenvold, M., et al. (2008). EORTC QLQ-C30 reference values. Brussels: EORTC Quality of Life Group Publications. Scott, N. W., Fayers, P. M., Aaronson, N. K., Bottomley, A., de Graeff, A., Groenvold, M., et al. (2008). EORTC QLQ-C30 reference values. Brussels: EORTC Quality of Life Group Publications.
25.
go back to reference US Department of Health and Human Services Food and Drug Administration. (2006). Guidance for industry: Patient report outcome measures: use in clinical medical product development to support labelling claims: Draft guidance. Health and Quality of Life Outcomes, 4, 79.CrossRef US Department of Health and Human Services Food and Drug Administration. (2006). Guidance for industry: Patient report outcome measures: use in clinical medical product development to support labelling claims: Draft guidance. Health and Quality of Life Outcomes, 4, 79.CrossRef
26.
go back to reference Sprangers, M. A. G., Cull, A., Bjordal, K., et al., & for the EORTC Study Group on Quality of Life. (1994). The European Organization for Research and Treatment of Cancer approach to the quality of life (QOL) assessment: Guidelines for developing questionnaire modules. Quality of Life Research, 3, 67–68. Sprangers, M. A. G., Cull, A., Bjordal, K., et al., & for the EORTC Study Group on Quality of Life. (1994). The European Organization for Research and Treatment of Cancer approach to the quality of life (QOL) assessment: Guidelines for developing questionnaire modules. Quality of Life Research, 3, 67–68.
27.
go back to reference Horton, N., Lipsitz, S., & Parzen, M. (2003). A potential for bias when rounding in multiple imputation. The American Statistician, 57, 229–232.CrossRef Horton, N., Lipsitz, S., & Parzen, M. (2003). A potential for bias when rounding in multiple imputation. The American Statistician, 57, 229–232.CrossRef
28.
go back to reference Allison, P. (2005). Imputation of categorical variables with PROC MI. Paper presented at SAS Users Group International, Annual conference, Philadelphia. Allison, P. (2005). Imputation of categorical variables with PROC MI. Paper presented at SAS Users Group International, Annual conference, Philadelphia.
Metagegevens
Titel
Longitudinal quality of life data: a comparison of continuous and ordinal approaches
Auteurs
A. F. Donneau
M. Mauer
C. Coens
A. Bottomley
A. Albert
Publicatiedatum
01-12-2014
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 10/2014
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-014-0730-8

Andere artikelen Uitgave 10/2014

Quality of Life Research 10/2014 Naar de uitgave